FDA Warns on Hepatitis C Drugs

The Food and Drug Administration is warning about the risk of reactivation of hepatitis B among patients who have had that disease and who are taking some prominent and expensive newer medicines for hepatitis C.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news